ArticleBMC cancer2021

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy.

Seo Ree Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.